Advertisement

European Cytokine Network

, Volume 28, Issue 1, pp 36–40 | Cite as

Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis

  • Shima Mahmoudi
  • Babak Pourakbari
  • Setareh Mamishi
Research Article

Abstract

Tuberculosis control relies on the identification and preventive treatment of people who are latently infected with Mycobacterium tuberculosis (Mtb). PE/PPE proteins have been reported to elicit CD4 and/or CD8 responses either in the form of whole recombinant proteins or as individual peptides. Very few of the PE and PPE proteins have been previously tested for responses in patients with TB and healthy donors. This is the first study to evaluate the Interferon Gamma Release Assay (IGRA) after stimulation with PE35 and PPE68. The antigenspecific levels of IFN-γ following stimulation with QuantiFERON-TB gold in-tube (QFT-G-IT) antigens, and PE35 and PPE68 recombinant proteins were evaluated in 79 children and 102 adults, respectively. Using QFT-G-IT kit, latent tuberculosis infection (LTBI) was detected in 26 children (33%) and 41 adults (40%); IGRA following stimulation with PE35 and PPE68 recombinant proteins, was positive, respectively, in 36 (46%) and 32 (40.5%) children, respectively. In addition, 53 adults (52%) had positive results following stimulation with these two proteins. The sensitivity and specificity ofIGRAfollowing stimulation with recombinant PE35 in children were76%and 80%, and following stimulation with recombinant PPE68 in this group, it was 73% and 75%, respectively. Meanwhile, there is no gold standard test for LTBI. Our designed tests using PE35 and PPE68 PE/PPE proteins, two PE/PPE proteins not present in BCG vaccins, which elicit CD4 and/or CD8 responses, might be helpful for rapid diagnosis of TB and improve the detection of LTBI. However, further validation studies to determine the advantage of IGRAs using these proteins, alone or combined, are highly recommended.

Key words

Interferon Gamma Release Assay diagnostic method PE35 PPE68 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pourakbari B, Mamishi S, Mohammadzadeh M, Mahmoudi S. First line anti-tubercular drug resistance of Mycobacterium tuberculosis in Iran: a systematic review. Front Microbiol 2016; 7: 1139.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Sayes F, Pawlik A, Frigui W, et al. CD4+ T cells recognizing PE/PPE antigens directly or via cross reactivity are protective against pulmonary Mycobacterium tuberculosis infection. PLoS Pathog 2016; 12: e1005770.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Mahmoudi S, Mamishi S, Pourakbari B. Potential markers for the discrimination of active and latent tuberculosis infection: moving the research agenda forward. In: Tuberculosis, www.smgebooks.com.Google Scholar
  4. 4.
    Mamishi S, Pourakbari B, Marjani M, Mahmoudi S. Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-γ release assays and the tuberculin skin test. Br J Biomed Sci 2014; 71: 115–24.CrossRefPubMedGoogle Scholar
  5. 5.
    Barcellini L, Borroni E, Brown J, et al. First independent evaluation of QuantiFERON-TB Plus performance. Eur Respir J 2016; 47: 1587–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Pourakbari B, Mamishi S, Marjani M, Rasulinejad M, Mariotti S, Mahmoudi S. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family. Mol Diagn Ther 2015; 19: 309–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Fishbein S, van Wyk N, Warren RM, Sampson SL. Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity. Mol Microbiol 2015; 96: 901–16.CrossRefPubMedGoogle Scholar
  8. 8.
    Copin R, Coscollá M, Seiffert SN, et al. Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition. mBio 2014; 5: e00960–13.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin Dev Immunol 2011; 2011: 497203.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mahmoudi S, Mamishi S, Ghazi M, Hosseinpour Sadeghi R, Pourakbari B. Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens. Iran J Microbiol 2014; 5: 374–8.Google Scholar
  11. 11.
    Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 1990; 132: 191–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Yoshiyama T, Harada N, Higuchi K, Sekiya Y, Uchimura K. Use of the QuantiFERON®-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis 2010; 14: 819–27.PubMedGoogle Scholar
  14. 14.
    Chiappini E, Bonsignori F, Accetta G, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review. Int J Immunopathol Pharmacol 2012; 25: 335–43.CrossRefPubMedGoogle Scholar
  15. 15.
    Cerezales MS, Benítez JD. Diagnosis of tuberculosis infection using interferon-γ-based assays. Enferm Infecc Microbiol Clin 2011; 29: 26–33.CrossRefGoogle Scholar
  16. 16.
    Mamishi S, Pourakbari B, Marjani M, Bahador A, Mahmoudi S. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker. J Infect 2015; 70:429.CrossRefPubMedGoogle Scholar
  17. 17.
    Mamishi S, Pourakbari B, Teymuri M, et al. Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2014; 33: 2111–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88–99.CrossRefPubMedGoogle Scholar
  19. 19.
    Mamishi S, Pourakbari B, Shams H, Marjani M, Mahmoudi S. Improving T-cell assays for diagnosis of latent TB infection: confirmation of the potential role of testing interleukin-2 release in Iranian patients. Allergol Immunopathol (Madr) 2016; 44: 314–21.CrossRefGoogle Scholar
  20. 20.
    Hoffmann H, Avsar K, Göres R, Mavi SC, Hofmann-Thiel S. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clin Microbiol Infect 2016; 22: 701–3.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2017

Authors and Affiliations

  • Shima Mahmoudi
    • 1
  • Babak Pourakbari
    • 1
  • Setareh Mamishi
    • 1
    • 2
  1. 1.Pediatric Infectious Disease Research CenterTehran University of Medical SciencesTehranIran
  2. 2.Department of Infectious Diseases, Pediatrics Center of Excellence, Children’s Medical CenterTehran University of Medical SciencesTehranIran

Personalised recommendations